Locations:
Search
Luspatercept shows promise for patients with few options
Even when cancer clinical trials are available, fewer eAYAs than children enroll
Searching for new insights into drug resistance, collateral sensitivity
A central hub for patient care and research expands Cleveland Clinic's world-class care around the globe
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
These research results will have impact in 2020
20 years of data suggest that ablation is a valid treatment option
Following the diagnostic clues to a rare cancer
Knocking out, then restoring, the immune system holds great promise
Molecular study suggests an update to AJCC guidelines
Capecitabine-based approach shows promise in a population with few options
Advertisement
Advertisement